Precision Medicine Online

Call Website

Precision Medicine Online Precision Medicine Online is published by GenomeWeb, an independent online news organization.

Revolution's RAS inhibitor may be approved in an all-comer population, but molecular profiling remains key to treatment ...
09/01/2026

Revolution's RAS inhibitor may be approved in an all-comer population, but molecular profiling remains key to treatment strategy, clinical trials, and next-generation drugs.

Experts question the value of direct-to-consumer advertising for multi-cancer early detection tests, but developers coun...
08/31/2026

Experts question the value of direct-to-consumer advertising for multi-cancer early detection tests, but developers counter that even low sensitivity is sometimes better than the alternatives.

University of Toronto researchers are betting yes, pointing to tRNA's ease of administration and efficacy advantages ove...
08/28/2026

University of Toronto researchers are betting yes, pointing to tRNA's ease of administration and efficacy advantages over other genetic medicines.

Sangrail Biologics is already discussing with the FDA a regulatory path for the gene therapy that Abeona Therapeutics dr...
08/27/2026

Sangrail Biologics is already discussing with the FDA a regulatory path for the gene therapy that Abeona Therapeutics dropped.

Researchers found that NGS testing use rose only slightly in the years after CMS began covering the tests nationally for...
08/20/2026

Researchers found that NGS testing use rose only slightly in the years after CMS began covering the tests nationally for advanced cancer patients.

The rise of expensive precision therapies has spawned a growing industry of auxiliary health benefit companies promising...
08/20/2026

The rise of expensive precision therapies has spawned a growing industry of auxiliary health benefit companies promising to get employees better care at a lower price.

The Center for Transformative Therapeutics is setting up infrastructure so different departments aren't reinventing the ...
08/20/2026

The Center for Transformative Therapeutics is setting up infrastructure so different departments aren't reinventing the wheel for each novel treatment.

The firm reported median overall survival of 26 months in patients with recurrent, high-grade, IDH1-mutant gliomas in a ...
08/12/2026

The firm reported median overall survival of 26 months in patients with recurrent, high-grade, IDH1-mutant gliomas in a Phase II study.

Revenue from the CAR T-cell therapy for later-line acute lymphoblastic leukemia more than doubled year-over-year.
08/11/2026

Revenue from the CAR T-cell therapy for later-line acute lymphoblastic leukemia more than doubled year-over-year.

Address

New York, NY

Telephone

+12122694747

Website

Alerts

Be the first to know and let us send you an email when Precision Medicine Online posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category